Agomab Therapeutics NV (AGMB)
Market Open
11 Sep, 15:16
NASDAQ (NMS) NASDAQ (NMS) Primary $
13. 70
-0.24
-1.7217%
$
686.52M Market Cap
- P/E Ratio
- Div Yield
46,814 Volume
- Eps
$ 13.94
Previous Close 
Analysts:
Want to track AGMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agomab Therapeutics NV (AGMB) Statistics
Valuation metrics
Market Cap 686.52M
Enterprise value 448.45M
Trailing P/E (ttm) -17.19
Forward P/E -
PEG ratio -0.17
Price/Sales (ttm) -
Price/Book (mrq) 2.49
Enterprise Value/Revenue -
Enterprise Value/EBITDA -12.57
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 199.75K
Average volume (90 days) 124.8K
Price summary
52-Week low 8.75
52-Week high 17.82
Beta -
50-Day moving average 13.45
200-Day moving average 12.31
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.12%
Return on equity -0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.73
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.17
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 12.88%
Book value per share (mrq) 5.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
